Second Sight Medical Prod...

NASDAQ: EYES · Real-Time Price · USD
4.14
-0.22 (-5.05%)
At close: Aug 31, 2022, 4:00 AM

Company Description

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction.

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals.

It develops technologies to treat the population of sight-impaired individuals.

The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.

The company was founded in 1998 and is headquartered in Sylmar, California.

Second Sight Medical Products Inc.
Second Sight Medical Products Inc. logo
Country United States
IPO Date Nov 19, 2014
Industry Medical - Devices
Sector Healthcare
Employees 15
CEO Matthew Pfeffer

Contact Details

Address:
12744 San Fernando Rd Bldg 3
Sylmar, CALIFORNIA
United States
Website https://www.secondsight.com

Stock Details

Ticker Symbol EYES
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001266806
CUSIP Number 81362J209
ISIN Number US81362J2096
Employer ID 00-0000000
SIC Code 3845

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
May 14, 2025 4 Filing
May 14, 2025 4 Filing
May 14, 2025 4 Filing
May 14, 2025 4 Filing
May 14, 2025 4 Filing
May 13, 2025 10-Q Quarterly Report
May 13, 2025 8-K Current Report
May 06, 2025 DEFR14A Filing
Apr 29, 2025 ARS Filing
Apr 29, 2025 DEFA14A Filing